Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.

<< Back to News

10/11/18 DC -- IV diphenhydramine

From: David Collette
To: grp allpharm
Cc: Andrea M. Evans
Sent: Thursday, October 11, 2018 8:54:21 AM
Subject: IV diphenhydramine

Thanks for reviewing Sentri-7 and medication profiles. We are down to 11 patients with an active order for IV diphenhydramine...please continue to review and switch to PO unless the patient is being treated for a severe/anaphylactic reaction. If they are unable to take PO, the physician should be contacted for an alternate agent for itching, allergic rhinitis, insomnia, or other non-life-threatening symptom.

 

IV diphenhydramine will be removed from most Pyxis machines today; exceptions include EDs and central Pyxis machines in OR areas. Going forward, pharmacists should only verify orders for IV diphenhydramine in severe/anaphylactic reaction situations.

 

DAVID

--

David R. Collette, Pharm.D., FASHP
Operations Manager, Professional Services






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved